Previous Article | Next Article 
J Virol, July 1998, p. 5757-5761, Vol. 72, No. 7
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Protective Immunity Induced by Oral Immunization
with a Rotavirus DNA Vaccine Encapsulated in Microparticles
Shing C.
Chen,1
David H.
Jones,2
Ellen F.
Fynan,1,3
Graham H.
Farrar,2
J. Christopher S.
Clegg,2
Harry B.
Greenberg,4 and
John E.
Herrmann1,*
Division of Infectious Diseases and
Immunology, University of Massachusetts Medical School, Worcester,
Massachusetts 016551;
Center for Applied
Microbiology and Research, Salisbury SP4 OJG, United
Kingdom2;
Department of Biology,
Worcester State College, Worcester, Massachusetts
016023; and
Division of
Gastroenterology, Stanford University School of Medicine, Stanford,
California 943044
Received 23 December 1997/Accepted 26 March 1998
DNA vaccines are usually given by intramuscular injection or by
gene gun delivery of DNA-coated particles into the epidermis. Induction
of mucosal immunity by targeting DNA vaccines to mucosal surfaces may
offer advantages, and an oral vaccine could be effective for
controlling infections of the gut mucosa. In a murine model, we
obtained protective immune responses after oral immunization with a
rotavirus VP6 DNA vaccine encapsulated in poly(lactide-coglycolide) (PLG) microparticles. One dose of vaccine given to BALB/c mice elicited
both rotavirus-specific serum antibodies and intestinal immunoglobulin
A (IgA). After challenge at 12 weeks postimmunization with homologous
rotavirus, fecal rotavirus antigen was significantly reduced compared
with controls. Earlier and higher fecal rotavirus-specific IgA
responses were noted during the peak period of viral shedding, suggesting that protection was due to specific mucosal immune responses. The results that we obtained with PLG-encapsulated rotavirus
VP6 DNA are the first to demonstrate protection against an infectious
agent elicited after oral administration of a DNA vaccine.
*
Corresponding author. Mailing address: Division of
Infectious Diseases, University of Massachusetts Medical School, 55 Lake Ave. North, Worcester, MA 01655. Phone: (508) 856-2155. Fax: (508) 856-5981. E-mail: John.E.Herrmann{at}banyan.ummed.edu.
J Virol, July 1998, p. 5757-5761, Vol. 72, No. 7
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Garaicoechea, L., Olichon, A., Marcoppido, G., Wigdorovitz, A., Mozgovoj, M., Saif, L., Surrey, T., Parreno, V.
(2008). Llama-Derived Single-Chain Antibody Fragments Directed to Rotavirus VP6 Protein Possess Broad Neutralizing Activity In Vitro and Confer Protection against Diarrhea in Mice. J. Virol.
82: 9753-9764
[Abstract]
[Full Text]
-
Naito, T., Kaneko, Y., Kozbor, D.
(2007). Oral vaccination with modified vaccinia virus Ankara attached covalently to TMPEG-modified cationic liposomes overcomes pre-existing poxvirus immunity from recombinant vaccinia immunization. J. Gen. Virol.
88: 61-70
[Abstract]
[Full Text]
-
Munoz-Montesino, C., Andrews, E., Rivers, R., Gonzalez-Smith, A., Moraga-Cid, G., Folch, H., Cespedes, S., Onate, A. A.
(2004). Intraspleen Delivery of a DNA Vaccine Coding for Superoxide Dismutase (SOD) of Brucella abortus Induces SOD-Specific CD4+ and CD8+ T Cells. Infect. Immun.
72: 2081-2087
[Abstract]
[Full Text]
-
Decaro, N., Pratelli, A., Tinelli, A., Martella, V., Camero, M., Buonavoglia, D., Tempesta, M., Caroli, A. M., Buonavoglia, C.
(2004). Fecal Immunoglobulin A Antibodies in Dogs Infected or Vaccinated with Canine Coronavirus. CVI
11: 102-105
[Abstract]
[Full Text]
-
Wang, X., Hone, D. M., Haddad, A., Shata, M. T., Pascual, D. W.
(2003). M Cell DNA Vaccination for CTL Immunity to HIV. J. Immunol.
171: 4717-4725
[Abstract]
[Full Text]
-
Al-Mariri, A., Tibor, A., Lestrate, P., Mertens, P., De Bolle, X., Letesson, J.-J.
(2002). Yersinia enterocolitica as a Vehicle for a Naked DNA Vaccine Encoding Brucella abortus Bacterioferritin or P39 Antigen. Infect. Immun.
70: 1915-1923
[Abstract]
[Full Text]
-
O'Hagan, D., Singh, M., Ugozzoli, M., Wild, C., Barnett, S., Chen, M., Schaefer, M., Doe, B., Otten, G. R., Ulmer, J. B.
(2001). Induction of Potent Immune Responses by Cationic Microparticles with Adsorbed Human Immunodeficiency Virus DNA Vaccines. J. Virol.
75: 9037-9043
[Abstract]
[Full Text]
-
Iturriza-Gómara, M., Green, J., Brown, D. W. G., Ramsay, M., Desselberger, U., Gray, J. J.
(2000). Molecular Epidemiology of Human Group A Rotavirus Infections in the United Kingdom between 1995 and 1998. J. Clin. Microbiol.
38: 4394-4401
[Abstract]
[Full Text]
-
Yuan, L., Geyer, A., Hodgins, D. C., Fan, Z., Qian, Y., Chang, K.-O., Crawford, S. E., Parreño, V., Ward, L. A., Estes, M. K., Conner, M. E., Saif, L. J.
(2000). Intranasal Administration of 2/6-Rotavirus-Like Particles with Mutant Escherichia coli Heat-Labile Toxin (LT-R192G) Induces Antibody-Secreting Cell Responses but Not Protective Immunity in Gnotobiotic Pigs. J. Virol.
74: 8843-8853
[Abstract]
[Full Text]
-
Xiang, Z. Q., Pasquini, S., Ertl, H. C. J.
(1999). Induction of Genital Immunity by DNA Priming and Intranasal Booster Immunization with a Replication-Defective Adenoviral Recombinant. J. Immunol.
162: 6716-6723
[Abstract]
[Full Text]
-
Wu, Y., Wang, X., Csencsits, K. L., Haddad, A., Walters, N., Pascual, D. W.
(2001). M cell-targeted DNA vaccination. Proc. Natl. Acad. Sci. USA
98: 9318-9323
[Abstract]
[Full Text]